日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening.

利用基于结构的虚拟筛选方法鉴定和生物学评价一种靶向胰腺癌中选择性剪接的新型 CLK4 抑制剂

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202416323
Yang Chun-Lin, Wu Yi-Wen, Tu Huang-Ju, Yeh Yun-Hsuan, Lin Tony Eight, Sung Tzu-Ying, Li Mu-Chun, Yen Shih-Chung, Hsieh Jui-Hua, Yu Ming-Chin, Hsieh Sen-Yung, Hsieh Hsing-Pang, Pan Shiow-Lin, Hsu Kai-Cheng
肿瘤
胰腺癌
发表日期：2025
文献求助 收藏

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

对当前新冠肺炎研究进展的关键概述：疫苗、抗病毒药物和治疗性抗体的研发

期刊:Journal of Biomedical Science
影响因子:12.1
doi:10.1186/s12929-022-00852-9
Kumari, Monika; Lu, Ruei-Min; Li, Mu-Chun; Huang, Jhih-Liang; Hsu, Fu-Fei; Ko, Shih-Han; Ke, Feng-Yi; Su, Shih-Chieh; Liang, Kang-Hao; Yuan, Joyce Pei-Yi; Chiang, Hsiao-Ling; Sun, Cheng-Pu; Lee, I-Jung; Li, Wen-Shan; Hsieh, Hsing-Pang; Tao, Mi-Hua; Wu, Han-Chung
肺炎
新冠
微生物学
发表日期：2022
文献求助 收藏

Mimicking H3 Substrate Arginine in the Design of G9a Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational Study for Structure-Based Drug Design

在癌症治疗中，通过模拟H3底物精氨酸来设计G9a赖氨酸甲基转移酶抑制剂：基于结构的药物设计的计算研究

期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.0c04710
Chandar Charles, M Ramya; Li, Mu-Chun; Hsieh, Hsing-Pang; Coumar, Mohane Selvaraj
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Design of drug-like hepsin inhibitors against prostate cancer and kidney stones

设计用于治疗前列腺癌和肾结石的类药物肝素抑制剂

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2019.09.008
Blay, Vincent; Li, Mu-Chun; Ho, Sunita P; Stoller, Mashall L; Hsieh, Hsing-Pang; Houston, Douglas R
肿瘤
肿瘤免疫
毒理研究
肾结石
前列腺癌
发表日期：2020
文献求助 收藏